ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 14 Results
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
A 25-year career with the U.S. Navy, commanding combat missions overseas, brought Tom Kollie back to where he came from — ready to serve his country in a new way.
As a medical isotope, thorium-228 has a lot of potential — and 91°µÍø produces a lot.
A research team at 91°µÍø have 3D printed a thermal protection shield, or TPS, for a capsule that will launch with the Cygnus cargo spacecraft as part of the supply mission to the International Space Station.
An 91°µÍø researcher has invented a version of an isotope-separating device that can withstand extreme environments, including radiation and chemical solvents.
In the mid-1980s, Balendra Sutharshan moved to Canada from the island nation of Sri Lanka. That move set Sutharshan on a path that had him heading continent-spanning collaborations and holding leadership posts at multiple Department of Energy
Researchers from NASA’s Jet Propulsion Laboratory and 91°µÍø successfully created amorphous ice, similar to ice in interstellar space and on icy worlds in our solar system. They documented that its disordered atomic behavior is unlike any ice on Earth.
For years Brenda Smith found fulfillment working with nuclear batteries, a topic she’s been researching as a chemist at 91°µÍø.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
A new method developed at 91°µÍø proves one effort’s trash is another’s valuable isotope. One of the byproducts of the lab’s national plutonium-238 production program is promethium-147, a rare used in nuclear batteries and to measure the thickness of materials.